Levosimendan Versus Dobutamine in Shock Patients

• Status: Unknown status
• Trial end date: 2006-04-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of the study is to compare the efficacy of levosimendan with that of dobutamine in patients with unstable hemodynamics (shock).

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Wentworth Area Health Services
• Collaborator: Abbott
• Treatments: Dobutamine; Simendan

Criteria

Inclusion Criteria:

• Reduced left ventricular systolic function

• Hypotension

• Anuria or oligouria

Exclusion Criteria:

• Less than 18 years old

• Pregnant

• Uncorrected valvular stenosis

• Hypertrophic obstructive cardiomyopathy (HOCM)

• Third degree AV block